Month: July 2023

TORONTO and MINNEAPOLIS, July 12, 2023 (GLOBE NEWSWIRE) — Ceridian HCM Holding Inc. (“Ceridian”) (NYSE:CDAY) (TSX:CDAY), a global leader in human capital management (HCM) technology, announced today that it will release second quarter 2023 financial results after the close of regular market trading on Wednesday, August 2, 2023. Ceridian will host a live webcast at 5:00 p.m. Eastern Time on August 2, 2023 to discuss the aforementioned financial results. The event can be accessed via direct registration link or through the Investor Relations section of Ceridian’s website. A recording of the event will be made available on the Investor Relations section of Ceridian’s website following the call. About Ceridian Ceridian. Makes Work Life Better™. Ceridian is a global human capital management software company. Dayforce®, its flagship...

Accomplished Industry Veteran Brings Deep Strategic and Operational Expertise CAMBRIDGE, Mass., July 12, 2023 (GLOBE NEWSWIRE) — Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced the appointment of Chris Schade to its Board of Directors. Mr. Schade brings over 30 years of experience across the biopharma industry to support the Company’s long-term growth objectives. “We are thrilled to welcome Chris to Omega’s Board of Directors as we advance our pipeline through key milestones in 2023 and beyond,” said Noubar Afeyan, Omega co-founder and Chairman of the Board. “His diverse experience and insights will play a key role in solidifying Omega’s long-term vision to pioneer a new class of programmable...

NEW YORK and LEAMINGTON, Ontario, July 12, 2023 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that the Company will release financial results for its fourth quarter and full fiscal year ended May 31, 2023 on July 26, 2023. Live Audio Webcast Tilray will host a live audio webcast to discuss these results at 8:30 am Eastern Time, which can be accessed on the Investors section of Tilray’s website at www.Tilray.com. A replay will be available and archived on the Company’s website. Retail Investor Q&A Tilray Brands stockholders can submit and upvote questions via the stockholder Q&A platform Say Technologies beginning today and until July 25, 2023. To submit questions ahead of the webcast,...

U.S. Navy T-45 Goshawk training aircraft NAVAIR Selects Mercury to Deliver Digital Head-Up Display for T-45 Goshawk Training AircraftANDOVER, Mass., July 12, 2023 (GLOBE NEWSWIRE) — Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a technology company that delivers processing power for the most demanding aerospace and defense missions, received a five-year contract worth as much as $83 million from the U.S. Naval Air Systems Command to deliver high-definition, digital Head-Up Display (HUD) systems for the T-45 Goshawk training aircraft. This firm-fixed-price delivery order was issued under a previously awarded basic ordering agreement. The Navy is the first customer to adopt Mercury’s HUD1080 technology that enables aviators to see critical flight and weapons data in real-time without taking their eyes off the sky. Under...

The Extended Agreement Term is Until March 2026 The Company Generated Approximately $16 Million in Revenue from Sales of KEDRAB to Kedrion in 2022 and Anticipates a Significant Increase in 2023REHOVOT, Israel, and HOBOKEN, N.J., July 12, 2023 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA) (“Kamada” or the “Company”), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that Kedrion has exercised its option to extend the distribution agreement between the parties in the U.S. for KEDRAB® (Rabies Immune Globulin [Human]), which is indicated for passive, transient post-exposure prophylaxis (PEP) of rabies infection to persons of all ages when given immediately after contact...

Consumer Education and Promotions in Select Markets Call Out Anniversary of the Controlled Substances Act CHICAGO and VANCOUVER, British Columbia, July 12, 2023 (GLOBE NEWSWIRE) — RISE Dispensaries, a rapidly growing cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or “the Company”) (CSE: GTII) (OTCQX: GTBIF), today announced the launch of its “Thanks, Dick” campaign, which will roll out across RISE Dispensaries in select markets on July 14th, to ironically “celebrate” Richard Nixon’s signing of the Controlled Substances Act in 1970. The “Thanks, Dick” campaign recognizes the destructive consequences of the Controlled Substances Act, which effectively initiated the War on Drugs and decades of harm on communities of color. “Nixon’s Controlled Substances Act was an ill-conceived, targeted policy that brought...

Axsome to host conference call and webcast on Monday, Aug. 7, 2023, at 8:00 a.m. Eastern Time NEW YORK, July 12, 2023 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that it will report its financial results for the second quarter of 2023 on Monday, Aug. 7, 2023, before the opening of the U.S. financial markets. Axsome’s management team will host a conference call at 8:00 a.m. Eastern Time on Aug. 7, 2023, to discuss these results and provide a business update. To participate in the live conference call, please dial (877) 405-1239 (toll-free domestic). A live webcast of the conference call can be accessed on the “Webcasts & Presentations” page of the “Investors” section...

VANCOUVER, British Columbia, July 12, 2023 (GLOBE NEWSWIRE) — Marimaca Copper Corp. (“Marimaca Copper”, “Marimaca” or the “Company”) (TSX: MARI) is pleased to announce the closing of the previously announced C$20 million equity investment by Mitsubishi Corporation (“Mitsubishi”) by way of non-brokered private placement (the “Strategic Investment”). Proceeds from the Strategic Investment will be used to advance and accelerate the development of the Company’s flagship Marimaca Copper Project located in the Antofagasta region, Chile. Pursuant to the Strategic Investment, Mitsubishi acquired an aggregate of 4,640,371 units (“Units”) consisting of one common share (a “Common Share”) and one Common Share purchase warrant (a “Warrant”) at a price of C$4.31 per Unit. Each Warrant will entitle Mitsubishi to purchase one additional Common...